Published in J Exp Med on December 01, 1986
Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev (2007) 4.79
Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J Exp Med (1988) 2.08
Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help). J Exp Med (1992) 2.03
Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J Exp Med (1988) 1.95
Activation of LFA-1 through a Ca2(+)-dependent epitope stimulates lymphocyte adhesion. J Cell Biol (1991) 1.72
Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J Exp Med (1994) 1.55
Triggered human mucosal T cells release tumour necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cells. Clin Exp Immunol (1991) 1.55
Utility of flow cytometric detection of CD69 expression as a rapid method for determining poly- and oligoclonal lymphocyte activation. Clin Diagn Lab Immunol (1996) 1.51
CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis. J Clin Invest (2003) 1.41
Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue. J Virol (2004) 1.32
Protein tyrosine phosphatase CD148-mediated inhibition of T-cell receptor signal transduction is associated with reduced LAT and phospholipase Cgamma1 phosphorylation. Mol Cell Biol (2001) 1.21
HIV-1 induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo. Blood (2007) 1.19
An Epstein-Barr virus-associated superantigen. J Exp Med (1996) 1.17
Involvement of Prep1 in the alphabeta T-cell receptor T-lymphocytic potential of hematopoietic precursors. Mol Cell Biol (2005) 1.17
Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism. Immunology (1993) 1.10
Dynamic changes during the immune response in T cell-antigen-presenting cell clusters isolated from lymph nodes. J Exp Med (2003) 1.08
Defective expression of p56lck in an infant with severe combined immunodeficiency. J Clin Invest (1998) 1.05
Selective suppressive effects of Trypanosoma cruzi on activated human lymphocytes. Infect Immun (1989) 1.01
Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue. J Virol (2005) 0.99
CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunology (1993) 0.98
ITM2A is induced during thymocyte selection and T cell activation and causes downregulation of CD8 when overexpressed in CD4(+)CD8(+) double positive thymocytes. J Exp Med (1999) 0.97
Hydrogen sulfide is an endogenous potentiator of T cell activation. J Biol Chem (2011) 0.96
Human T cell activation. IV. T cell activation and proliferation via the early activation antigen EA 1. J Exp Med (1989) 0.95
Heterogeneity of M-cell-associated B and T cells in human Peyer's patches. Immunology (1994) 0.93
CD69 is expressed on platelets and mediates platelet activation and aggregation. J Exp Med (1990) 0.91
Does immune activation continue during an attack-free period in familial Mediterranean fever? Clin Exp Immunol (2004) 0.91
Virus-encoded superantigens. Microbiol Rev (1996) 0.89
CD69 expression reliably predicts the anti-CD3-induced proliferative response of lymphocytes from human immunodeficiency virus type 1-infected patients. Clin Diagn Lab Immunol (1997) 0.87
Attenuation of lung inflammation and fibrosis in CD69-deficient mice after intratracheal bleomycin. Respir Res (2011) 0.86
Expression of early activation antigen (CD69) during human thymic development. Clin Exp Immunol (1990) 0.84
Expression of a gp33/27,000 MW activation inducer molecule (AIM) on human lymphoid tissues. Induction of cell proliferation on thymocytes and B lymphocytes by anti-AIM antibodies. Immunology (1989) 0.84
Distinct expression patterns of CD69 in mucosal and systemic lymphoid tissues in primary SIV infection of rhesus macaques. PLoS One (2011) 0.84
MHC Class II and CD9 in human eosinophils localize to detergent-resistant membrane microdomains. Am J Respir Cell Mol Biol (2011) 0.83
Expression of CD69 antigen on synovial fluid T cells in patients with rheumatoid arthritis and other chronic synovitis. Ann Rheum Dis (1993) 0.83
Surface proteins and glycoproteins of human leucocytes. Biochem J (1988) 0.83
Surface expression of a heterologous phosphatase complements CD45 deficiency in a T cell clone. J Exp Med (1994) 0.82
CD69 does not affect the extent of T cell priming. PLoS One (2012) 0.82
Decreased levels of CD54 (ICAM-1)-positive lymphocytes in the peripheral blood in untreated patients with active juvenile dermatomyositis. Clin Diagn Lab Immunol (2000) 0.82
CD69 expression on CD4+ T lymphocytes after in vitro stimulation with tuberculin is an indicator of immune sensitization against Mycobacterium tuberculosis antigens. Clin Diagn Lab Immunol (2005) 0.82
Lack of costimulation by both sphingomyelinase and C2 ceramide in resting human T cells. Immunology (2000) 0.81
Maternal CD4⁺ and CD8⁺ T cell tolerance towards a fetal minor histocompatibility antigen in T cell receptor transgenic mice. Biol Reprod (2013) 0.81
Early lymphocyte activation molecule defined by the monoclonal antibody MLR-3: biochemical and functional studies. Immunology (1988) 0.80
A whole-blood assay for qualitative and semiquantitative measurements of CD69 surface expression on CD4 and CD8 T lymphocytes using flow cytometry. Clin Diagn Lab Immunol (1998) 0.80
CD45 and RPTPalpha display different protein tyrosine phosphatase activities in T lymphocytes. Biochem J (1997) 0.79
T Cell Activation and Proinflammatory Cytokine Production in Clinically Cured Tuberculosis Are Time-Dependent and Accompanied by Upregulation of IL-10. PLoS One (2013) 0.78
Expression pattern of transcription factors and intracellular cytokines reveals that clinically cured tuberculosis is accompanied by an increase in mycobacterium-specific Th1, Th2, and Th17 cells. Biomed Res Int (2015) 0.77
Allopurinol reduces antigen-specific and polyclonal activation of human T cells. Front Immunol (2012) 0.77
CD69 is a TGF-β/1α,25-dihydroxyvitamin D3 target gene in monocytes. PLoS One (2013) 0.77
Trypanosoma cruzi immunosuppressive factor decreases the interleukin-2 mRNA level in cultured normal activated human lymphocytes. Infect Immun (1995) 0.76
Lack of transglutaminase 2 diminished T-cell responses in mice. Immunology (2014) 0.75
Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication in vitro and Modulate HIV Restriction Factor Expression. J Virol (2017) 0.75
Post-transplant immunosuppression: regulation of the efflux of allospecific effector T cells from lymphoid tissues. PLoS One (2012) 0.75
The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature (1984) 28.58
Tumor-promoting phorbol esters stimulate C3b and C3b' receptor-mediated phagocytosis in cultured human monocytes. J Exp Med (1982) 7.10
The role of the T3/antigen receptor complex in T-cell activation. Annu Rev Immunol (1986) 5.67
A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA. Cell (1985) 5.21
Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin. Proc Natl Acad Sci U S A (1981) 4.50
Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci U S A (1981) 4.34
Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells. J Exp Med (1979) 3.76
Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen). J Exp Med (1985) 3.48
Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). I. Characterization of B-lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions by flow cytometric analysis. Cell Immunol (1984) 3.36
The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. Science (1986) 3.32
Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A. J Exp Med (1986) 3.24
Sequential expression of genes involved in human T lymphocyte growth and differentiation. J Exp Med (1985) 3.04
Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J Immunol (1981) 3.02
Detection and characterization of high affinity plasma membrane receptors for human interleukin 1. J Exp Med (1985) 3.00
Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content. J Exp Med (1983) 2.94
B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas. J Immunol (1982) 2.93
1-(5-Isoquinolinesulfonyl)-2-methylpiperazine (H-7) is a selective inhibitor of protein kinase C in rabbit platelets. Biochem Biophys Res Commun (1984) 2.59
Protein kinase C activation by diacylglycerol second messengers. Cell (1986) 2.44
Human T cell activation. I. Monocyte-independent activation and proliferation induced by anti-T3 monoclonal antibodies in the presence of tumor promoter 12-o-tetradecanoyl phorbol-13 acetate. J Exp Med (1985) 2.41
Stimulation of human B lymphocytes by antibodies to IgM and IgG: functional evidence for the expression of IgG on B-lymphocyte surface membranes. Clin Immunol Immunopathol (1980) 2.00
Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts. Cell (1982) 1.95
Involvement of T44 molecules in an antigen-independent pathway of T cell activation. Analysis of the correlations to the T cell antigen-receptor complex. J Exp Med (1985) 1.92
Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. J Immunol (1984) 1.84
Detection and functional studies of p60-65 (Tac antigen) on activated human B cells. J Exp Med (1984) 1.84
gamma-Glutamyl transpeptidase, a lymphoid cell-surface marker: relationship to blastogenesis, differentiation, and neoplasia. Proc Natl Acad Sci U S A (1976) 1.78
T cell stimulation via the erythrocyte receptor. Synergism between monoclonal antibodies and phorbol myristate acetate without changes of free cytoplasmic Ca++ levels. J Exp Med (1986) 1.68
Comparative expression of T9, T10, and Ia antigens on activated human T cell subsets. Hum Immunol (1981) 1.57
Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody. Eur J Immunol (1985) 1.44
Pre-B cells and other possible precursor lymphoid cell lines derived from patients with X-linked agammaglobulinemia. J Exp Med (1980) 1.28
Alterations in isozymes of adenosine deaminase during stimulation of human peripheral blood lymphocytes. Cell Immunol (1974) 1.15
Membrane antigen on Epstein--Barr virus-infected human B cells recognized by a monoclonal antibody. Proc Natl Acad Sci U S A (1982) 1.13
TLiSA1, a human T lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursors. J Exp Med (1985) 1.11
Human blood monocytes and platelets share a cell surface component. Blood (1982) 1.10
B5, a new B cell-restricted activation antigen. J Immunol (1985) 1.08
Analysis of T cell activation with a non-mitogenic anti CD3 antibody and the phorbol ester TPA. Clin Exp Immunol (1985) 1.05
Selective inhibition of growth factor-dependent human B cell proliferation by monoclonal antibody AB1 to an antigen expressed by activated B cells. J Exp Med (1984) 1.00
Genetic and biochemical characterization of human lymphocyte cell surface antigens. The A-1A5 and A-3A4 determinants. J Exp Med (1984) 0.93
Cell surface galactosyltransferase and lectin agglutination of thymus and spleen lymphocytes. Proc Natl Acad Sci U S A (1974) 0.92
Expression of a 26,000-dalton glycoprotein on activated human T cells. Cell Immunol (1981) 0.90
An antigen characteristic of hairy cell leukemia cells is expressed on certain activated B cells. J Immunol (1984) 0.89
Effect of concanavalin A on expression of cell surface sialyltransferase activity of mouse thymocytes. Proc Natl Acad Sci U S A (1976) 0.89
Membrane protein synthesis in mitogen-stimulated human T lymphocytes. J Immunol (1981) 0.85
Receptor binding and internalization of immobilized transcobalamin II by mouse leukaemia cells. Nature (1980) 0.83
Properties of a surface antigen expressed on activated human thymus-derived lymphocytes. J Immunol (1982) 0.80
Adherence of L1210 murine leukemia cells to sephacryl-aminopropylcobalamin beads treated with transcobalamin-II. Blood (1980) 0.79
Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes. J Exp Med (1975) 4.96
IgG on lymphocyte surfaces; technical problems and the significance of a third cell population. J Immunol (1975) 4.92
A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J (1995) 3.78
Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells. J Exp Med (1979) 3.76
CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J Exp Med (1990) 3.67
Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen). J Exp Med (1985) 3.48
Evidence for linkage between HL-A histocompatibility genes and those involved in the synthesis of the second component of complement. J Exp Med (1974) 3.38
Ia-bearing T lymphocytes in man. Their identification and role in the generation of allogeneic helper activity. J Exp Med (1978) 3.18
EBV gene expression in an NPC-related tumour. EMBO J (1989) 2.94
Occurrence of surface IgM, IgD, and free light chains of human lymphocytes. J Exp Med (1974) 2.93
Skyrmion flow near room temperature in an ultralow current density. Nat Commun (2012) 2.87
Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization. J Exp Med (1980) 2.76
Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus. Arthritis Rheum (1975) 2.65
Structure of a cephalosporin synthase. Nature (1998) 2.59
Human T cell activation. I. Monocyte-independent activation and proliferation induced by anti-T3 monoclonal antibodies in the presence of tumor promoter 12-o-tetradecanoyl phorbol-13 acetate. J Exp Med (1985) 2.41
Induction of in vitro differentiation and immunoglobulin synthesis of human leukemic B lymphocytes. J Exp Med (1978) 2.39
Zyxin, a regulator of actin filament assembly, targets the mitotic apparatus by interacting with h-warts/LATS1 tumor suppressor. J Cell Biol (2000) 2.36
Similar idiotypic specificity for the membrane IgD and IgM of human B lymphocytes. J Immunol (1975) 2.28
Human T cell hybridomas secreting factors for IgA-specific help, polyclonal B cell activation, and B cell proliferation. J Exp Med (1982) 2.27
Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci U S A (1993) 2.17
The occurrence of the HL-B alloantigens on the cells of unclassified acute lymphoblastic leukemias. J Exp Med (1975) 2.13
Idiotypic specificity of surface immunoglobulin and the maturation of leukemic bone-marrow-derived lymphocytes. Proc Natl Acad Sci U S A (1974) 2.13
Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells. J Exp Med (1988) 2.07
Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody. J Exp Med (1988) 2.05
Stimulation of human B lymphocytes by antibodies to IgM and IgG: functional evidence for the expression of IgG on B-lymphocyte surface membranes. Clin Immunol Immunopathol (1980) 2.00
Automated detection of pulmonary nodules in helical CT images based on an improved template-matching technique. IEEE Trans Med Imaging (2001) 2.00
Induction of polyclonal antibody synthesis by human allogeneic and autologous helper factors. J Exp Med (1979) 1.98
The nature of the stimulatory cell in human allogeneic and autologous MLC reactions; role of isolated IgM-bearing B cells. J Immunol (1979) 1.96
Neurofibrillary tangles in senile dementia of the Alzheimer type share an antigenic determinant with intermediate filaments of the vimentin class. Am J Pathol (1983) 1.93
Mammalian cell mutants resistant to a sphingomyelin-directed cytolysin. Genetic and biochemical evidence for complex formation of the LCB1 protein with the LCB2 protein for serine palmitoyltransferase. J Biol Chem (1998) 1.89
An experimental study of a combination method using a pedicle screw and laminar hook for the osteoporotic spine. Spine (Phila Pa 1976) (1997) 1.88
Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation. J Immunol (1990) 1.86
Detection and functional studies of p60-65 (Tac antigen) on activated human B cells. J Exp Med (1984) 1.84
Lymphoblastoid cell lines from patients with chronic lymphocytic leukemia: identification of tumor origin by idiotypic analysis. Proc Natl Acad Sci U S A (1978) 1.78
Patterns of expression of human "Ia-like" antigens during the terminal stages of B cell development. J Immunol (1978) 1.76
T cell helper defect in patients with chronic lymphocytic leukemia. J Immunol (1979) 1.74
Critical roles of glycosylphosphatidylinositol for Trypanosoma brucei. Proc Natl Acad Sci U S A (2000) 1.69
B-cell alloantigen Ag 7a in multiple sclerosis. Lancet (1975) 1.67
Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat Genet (1994) 1.63
Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway. EMBO J (1996) 1.62
Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia. Proc Natl Acad Sci U S A (1999) 1.61
A novel protein that participates in nonself discrimination of malignant cells by homologous complement. Nat Med (1997) 1.61
Differentiation capacity and other properties of the leukemic cells of chronic lymphocytic leukemia. Immunol Rev (1979) 1.53
Activation of Akt/protein kinase B contributes to induction of ischemic tolerance in the CA1 subfield of gerbil hippocampus. J Cereb Blood Flow Metab (2001) 1.52
Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46). J Exp Med (1990) 1.49
Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen--a report from the study group for pediatric solid malignant tumors in the Kyushu area. J Pediatr Surg (2004) 1.48
Rapid somatic growth after birth in children with neuroblastoma: A survey of 1718 patients with childhood cancer in Kyushu-Okinawa district. J Pediatr (1999) 1.47
Two types of Ia-positive T cells. Synthesis and exchange of Ia antigens. J Exp Med (1980) 1.47
Ileosigmoid knot: case report and CT findings. Abdom Imaging (2005) 1.47
Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46
Anti-CD45 inhibition of human B cell proliferation depends on the nature of activation signals and the state of B cell activation. A study with anti-IgM and anti-CDw40 antibodies. J Immunol (1989) 1.45
Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase C gamma 2. J Exp Med (1994) 1.45
Diagnosis and management of partial anomalous pulmonary venous connection. A review of 28 pediatric cases. Cardiology (1998) 1.43
NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci. Clin Immunol (2001) 1.42
Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin Exp Immunol (2005) 1.42
Mixed lymphocyte culture determinants and C2 deficiency: LD-7a associated with C2 deficiency in four families. J Exp Med (1975) 1.40
Malignant germ cell tumors: clinical characteristics, treatment, and outcome. A report from the study group for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan. J Pediatr Surg (2002) 1.40
The loop-loosening procedure for urination difficulties after Stamey suspension of the vesical neck. J Urol (1990) 1.39
CCL13 is a promising diagnostic marker for systemic sclerosis. Br J Dermatol (2009) 1.39
Molecular analysis of the induction of immunoglobulin E synthesis in human B cells by interleukin 4 and engagement of CD40 antigen. J Exp Med (1992) 1.38
The acceleration of cosmic-ray protons in the supernova remnant RX J1713.7-3946. Nature (2002) 1.38
Temporary wound closure with used needles. J Cataract Refract Surg (1992) 1.38
A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease. Arthritis Rheum (1989) 1.37
Receptors for IgM on certain human B lymphocytes. J Immunol (1977) 1.37
Immunofluorescent studies on antibodies directed to a buried membrane structure present in lymphocytes and erythrocytes. J Immunol (1975) 1.36
Isolation and immunological characterization of a major surface glycoprotein (gp54) preferentially expressed on certain human B cells. J Exp Med (1979) 1.35
Brief exposure to low-pH stress causes irreversible damage to the growing root in Arabidopsis thaliana: pectin-Ca interaction may play an important role in proton rhizotoxicity. J Exp Bot (2001) 1.32
Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques. J Exp Med (1986) 1.32
Triggering of T cell proliferation through CD28 induces GATA-3 and promotes T helper type 2 differentiation in vitro and in vivo. Eur J Immunol (1999) 1.32
Symptoms of spinal stenosis do not improve after epidural steroid injection. Clin J Pain (1998) 1.32
Overexpression of mitochondrial citrate synthase in Arabidopsis thaliana improved growth on a phosphorus-limited soil. Plant Cell Physiol (2000) 1.31
STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice. Gut (2006) 1.30
Pre-B cells and other possible precursor lymphoid cell lines derived from patients with X-linked agammaglobulinemia. J Exp Med (1980) 1.28
CD28-induced T cell activation. Evidence for a protein-tyrosine kinase signal transduction pathway. J Immunol (1992) 1.27
"Equator ring" for maintenance of the completely circular contour of the capsular bag equator after cataract removal. Ophthalmic Surg (1991) 1.27
Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia. Proc Natl Acad Sci U S A (1994) 1.26
Xanthoma of the bladder. J Urol (1995) 1.26
Intra-alveolar macrophage-inflammatory peptide 2 induces rapid neutrophil localization in the lung. Am J Respir Cell Mol Biol (1996) 1.25
A mammalian homolog of the yeast LCB1 encodes a component of serine palmitoyltransferase, the enzyme catalyzing the first step in sphingolipid synthesis. J Biol Chem (1997) 1.25
Functional difference between Ad4BP and ELP, and their distributions in steroidogenic tissues. Mol Endocrinol (1994) 1.25
Role of Oncostatin M in hematopoiesis and liver development. Cytokine Growth Factor Rev (2000) 1.25
Poor mixed lymphocyte reaction stimulatory capacity of leukemic B cells of chronic lymphocytic leukemia patients despite the presence of Ia antigens. J Clin Invest (1979) 1.24
Human cell lines containing Epstein-Barr virus but distinct from the common B cell lymphoblastoid lines. Proc Natl Acad Sci U S A (1979) 1.24
Open total dislocation of the talus with extrusion (missing talus): report of two cases. Foot Ankle (1992) 1.23
Polyclonal immunoglobulin secretion in patients with common variable immunodeficiency using monoclonal B cell differentiation factors. J Clin Invest (1984) 1.23
Induction of HLA-DC/DS (LEU 10) antigen expression by human precursor B cell lines. J Exp Med (1983) 1.23
Gross demonstration of the mammalian atrioventricular bundle by a periodic acid-Schiff procedure. Stain Technol (1965) 1.22
Biogenesis of membrane-bound and secreted immunoglobulins. I. Two distinct translation products of human mu-chain, with identical N-termini and different C-termini. J Exp Med (1980) 1.21
Human UDP-galactose translocator: molecular cloning of a complementary DNA that complements the genetic defect of a mutant cell line deficient in UDP-galactose translocator. J Biochem (1996) 1.21
Cutting edge: dominant effect of Ile50Val variant of the human IL-4 receptor alpha-chain in IgE synthesis. J Immunol (1999) 1.20
Immunoregulatory role of CD40 in human B cell differentiation. J Immunol (1993) 1.20
Membrane immunoglobulins of B lymphocytes: inability to detect certain characteristic IgM and IgD antigens. J Exp Med (1974) 1.19
Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol (2000) 1.19